Healthcare · coverage May 22, 2024–Jul 21, 2026
Estimated market comparison · not an official filing fact
Available with Pro
Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.
Disclosure alert preview
Based on a real public filing
Alan Armstrong
$1K - $15K
This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Aug 13, 2026.
Official filingThis page summarizes public STOCK Act disclosures involving CVS. It is useful for seeing which lawmakers reported CVS transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Jul 21, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
Congressional Trader tracks 17 public STOCK Act disclosures for CVSacross 14 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent CVS filing shown here was filed on Jul 21, 2026 by Alan Armstrong as a purchase. Related lawmakers include Lisa C. McClain, Robert P. Bresnahan, Adam Smith, Alan Armstrong, Dwight Evans.
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansRecent CVS disclosures include Lisa C. McClain, Robert P. Bresnahan, Adam Smith, Alan Armstrong, Dwight Evans.
The visible sample currently shows 6 purchases and 11 sales or partial sales.
No. This page summarizes public filings for research and monitoring. It is not investment advice.
